Lumisight Side Effects

Generic name: pegulicianine

Note: This document provides detailed information about Lumisight.

Applies to pegulicianine: intravenous powder for injection Side Effects associated with pegulicianine. Some dosage forms listed on this page may not apply specifically to the brand name Lumisight.

Applies to pegulicianine: intravenous powder for injection.

Cardiovascular adverse events

• Frequency not reported: Hypotension, cyanosis^[Ref]

Dermatologic

• Frequency not reported: Pruritus, urticaria, erythema, maculopapular rash^[Ref]

Gastrointestinal

• Frequency not reported: Nausea, vomiting^[Ref]

Genitourinary

• Very common (10% or more): Chromaturia^[Ref]

Hematologic

• Frequency not reported: Extravasation^[Ref]

Hypersensitivity

• Frequency not reported: Anaphylaxis, lip swelling^[Ref]

Metabolic

• Frequency not reported: Pyrexia^[Ref]

Nervous system

• Frequency not reported: Chest pain, headache, hypoesthesia, paresthesia^[Ref]

Ocular

• Frequency not reported: Visual changes^[Ref]

Other

• Frequency not reported: Dizziness^[Ref]

Psychiatric

• Frequency not reported: Anxiety^[Ref]

Respiratory

• Frequency not reported: Dyspnea, hyperventilation^[Ref]

See also:

Further information

Lumisight side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer